BOULDER, Colo., Aug. 28 /PRNewswire-FirstCall/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E.
Conway, will speak at the Roth Capital Partners 2006 New York Conference on
September 6 in New York City. The public is welcome to participate in the
conference through an audio webcast on the Array BioPharma website.
Event: The Roth Capital Partners 2006 New York Conference
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Wednesday, September 6, 2006
Time: 4:00 pm Eastern Time
Location: The Westin New York at Times Square, New York City
Audio Webcast: http://www.arraybiopharma.com
About Array BioPharma:
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule
drugs to treat life threatening and debilitating diseases. Our proprietary
drug development pipeline is focused on the treatment of cancer and
inflammatory disease and includes clinical candidates that are designed to
regulate therapeutically important targets. In addition, leading
pharmaceutical and biotechnology companies collaborate with Array to
discover and develop drug candidates across a broad range of therapeutic
areas. For more information on Array, please go to http://www.arraybiopharma.com.
SOURCE Array BioPharma Inc.
 back to top
Related links:
http://www.arraybiopharma.com
CONTACT:
Tricia Haugeto of Array BioPharma Inc.,
+1-303-386-1193, thaugeto@arraybiopharma.com
|
